Alfie R Wearn
Overview
Explore the profile of Alfie R Wearn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isotalus H, Carr W, Blackman J, Averill G, Radtke O, Selwood J, et al.
Front Behav Neurosci
. 2024 Sep;
18:1478382.
PMID: 39262405
[This corrects the article DOI: 10.3389/fnbeh.2023.1096720.].
2.
Isotalus H, Carr W, Blackman J, Averill G, Radtke O, Selwood J, et al.
Front Behav Neurosci
. 2023 Apr;
17:1096720.
PMID: 37091594
Introduction: Millions of people worldwide take medications such as L-DOPA that increase dopamine to treat Parkinson's disease. Yet, we do not fully understand how L-DOPA affects sleep and memory. Our...
3.
Wearn A, Nurdal V, Saunders-Jennings E, Knight M, Madan C, Fallon S, et al.
Neuroimage
. 2021 Jun;
238:118214.
PMID: 34116150
A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2...
4.
Wearn A, Saunders-Jennings E, Nurdal V, Hadley E, Knight M, Newson M, et al.
Alzheimers Res Ther
. 2020 Sep;
12(1):119.
PMID: 32988418
Background: Here, we address a pivotal factor in Alzheimer's prevention-identifying those at risk early, when dementia can still be avoided. Recent research highlights an accelerated forgetting phenotype as a risk...
5.
Wearn A, Nurdal V, Saunders-Jennings E, Knight M, Isotalus H, Dillon S, et al.
Alzheimers Res Ther
. 2020 Sep;
12(1):105.
PMID: 32912337
Background: Early Alzheimer's disease (AD) diagnosis is vital for development of disease-modifying therapies. Prior to significant brain tissue atrophy, several microstructural changes take place as a result of Alzheimer's pathology....